Evidence map›Paper›PMID 28294115›Full record

ArticleNature communications2017

Phosphorylation of Rab-coupling protein by LMTK3 controls Rab14-dependent EphA2 trafficking to promote cell:cell repulsion.

Christine Gundry, Sergi Marco, Elena Rainero, Bryan Miller, Emmanuel Dornier, Louise Mitchell, Patrick T Caswell, Andrew D Campbell, Anna Hogeweg, Owen J Sansom and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Targeting the secretory program of 3q-amplified lung cancers.The Journal of clinical investigation · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Rab11FIP1-deficient mice develop spontaneous inflammation and show increased susceptibility to colon damage.American journal of physiology. Gastrointestinal and liver physiology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Christine GundryCRUK Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK.
Sergi MarcoCRUK Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK.
Elena RaineroCRUK Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK.
Bryan MillerCRUK Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK.
Emmanuel DornierCRUK Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK.
Louise MitchellCRUK Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK.
Patrick T CaswellCRUK Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK.ORCID 0000-0002-2633-2324
Andrew D CampbellCRUK Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK.
Anna HogewegCRUK Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK.
Owen J SansomCRUK Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK.ORCID 0000-0001-9540-3010
Jennifer P MortonCRUK Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK.
Jim C NormanCRUK Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK.
Cancer Research UK Scotland Institute · GBWellcome Centre for Cell-Matrix Research · GB

Funding

Cancer Research UK 18277Cancer Research UK 21139Medical Research Council MR/P01058X/1
6 · The paper itself

Abstract

The Rab GTPase effector, Rab-coupling protein (RCP) is known to promote invasive behaviour in vitro by controlling integrin and receptor tyrosine kinase (RTK) trafficking, but how RCP influences metastasis in vivo is unclear. Here we identify an RTK of the Eph family, EphA2, to be a cargo of an RCP-regulated endocytic pathway which controls cell:cell repulsion and metastasis in vivo. Phosphorylation of RCP at Ser

Indexed as

Adaptor Proteins, Signal TransducingAdenocarcinomaCell Line, TumorGene Knockout TechniquesHepatocyte Growth FactorHumansMembrane ProteinsModels, BiologicalNeoplasm InvasivenessNeoplasm MetastasisPancreatic NeoplasmsPhosphorylationPhosphoserineProtein BindingProtein Serine-Threonine KinasesProtein TransportAdaptor Proteins, Signal TransducingHepatocyte Growth FactorLMTK3 protein, humanMembrane ProteinsPhosphoserineProtein Serine-Threonine KinasesRAB11FIP1 protein, humanRab14 protein, humanrab GTP-Binding ProteinsReceptor, EphA2

Identifiers

PMID28294115
PMCPMC5355957
OpenAlexW2573195025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.